With the Affordable Care Act poised to become repealed, or at least changed, researchers sought to understand the health and healthcare utilization of people at risk to lose their insurance.
With President Donald J. Trump in the White House and Republicans controlling both the House of Representatives and the Senate, the Affordable Care Act (ACA) is almost guaranteed to be repealed, or at least modified. As a result, there should be a better understanding of health and healthcare use by individuals who are at risk of losing their insurance with a repeal of the ACA, wrote authors of a letter in JAMA Internal Medicine.
“Our analysis highlights the socioeconomic vulnerability and rates of chronic diseases and healthcare utilization of individuals at risk of lose health insurance if the ACA is modified or repealed such that premium tax credits are eliminated and Medicaid expansion is rolled back,” the authors wrote.
The researchers used the Integrated Health Interview Series of the 2015 National Health Interview Survey and identified 3 groups of adults under the age of 65 who were at risk of losing their health insurance through changes to or a repeal of the ACA.
The groups were as follows:
These adults were all more likely to be minorities, poor, and unemployed compared with adults with employer-sponsored insurance. Adults who have employer-sponsored insurance are unlikely to be affected by changes in subsidies or to Medicaid.
Adults in the groups more likely to lose their insurance had higher rates of self-reported poor health and were more likely to have visited the emergency department, been hospitalized, have a high number of physician officer visits, and have certain chronic diseases.
“The serious consequences for those at risk to lose coverage if premium tax credits and Medicaid expansion are rolled back are striking,” the authors concluded. “These consequences point to the challenges Congress should address before enacting new health care legislation.”
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More